|Articles|September 1, 2001
- Pharmaceutical Executive-09-01-2001
- Volume 0
- Issue 0
Legislation: EC Proposes Changes
Author(s)Kevin Gopal
European Union-Both prescription and over-the-counter (OTC) industry sectors have welcomed the long-awaited proposals to overhaul EU pharma legislation.
Advertisement
Articles in this issue
about 24 years ago
Profits and Promotion Under Attackabout 24 years ago
New Playing Fieldsabout 24 years ago
Inefficiencies: Cutting Through the Jungleabout 24 years ago
Flexing Their Budgets: Big Pharma Spend Trendsabout 24 years ago
Media Mix Town Meeting 2001: Much Ado About MediaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
2
Organon CEO Kevin Ali to Resign Following Internal Investigation into Nexplanon Sales
3
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
4
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
5
